Colinz Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

39.00 0.00

22 March 2023, 11:56:00 AM
Volume: 3

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.findoc-cll.in
Market Cap 9.82 Cr.
Enterprise Value(EV) 4.69 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.59 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 24.56 Trailing Twelve Months Ending 2022-12
Industry PE 31.70 Trailing Twelve Months Ending 2022-12
Book Value / Share 31.99 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.22 Calculated using Price: 39.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.25 Cr. 2,519,100 Shares
FaceValue 10
Company Profile
Pharmaceutical Formulations (of all dosages forms) TabletsCapsulesParenteralsCreams/ Ointments/LotionsDry PowderLiquid OralsSoft Gelatine Capsules

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-2.26%
1 Month
+1.56%
3 Month
-13.14%
6 Month
-13.33%
1 Year
+44.98%
2 Year
+392.42%
5 Year
+167.12%
10 Year
+492.71%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 1.06 1.55 1.52 2.21 3.48 1.79 1.91 2.94 4.53
Return on Capital Employed (%) 2.52 3.12 3.27 3.12 3.25 3.45 3.30 4.28 6.76
Return on Assets (%) 0.67 0.94 0.93 1.45 2.39 1.30 1.45 2.20 3.39

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 6 6 6 7 7 7 7 7 8 8
Non Curr. Liab. 2 3 2 1 1 1 0 0 0 0
Curr. Liab. 1 2 1 2 2 2 2 3 2 2
Minority Int.
Equity & Liab. 10 11 10 10 10 9 9 10 10 11
Non Curr. Assets 6 5 4 4 4 4 3 3 3 3
Curr. Assets 4 6 5 5 6 6 6 7 7 8
Misc. Exp. not W/O
Total Assets 10 11 10 10 10 9 9 10 10 11

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 7 8 8 8 8 8 8 6 7 7
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 8 8 8 8 8 8 8 6 7 7
Total Expenditure -7 -7 -8 -8 -8 -7 -7 -6 -6 -6
PBIDT 0 1 1 1 0 0 0 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 1 0 0 1 1 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 1 0 1 0 0 0 1 2 0
Cash Fr. Inv. 0 0 0 0 0 0 0
Cash Fr. Finan. 0 0 0 -1 0 0 0 0 0 0
Net Change 0 0 1 0 0 0 0 1 2 1
Cash & Cash Eqvt 1 1 2 2 2 2 2 3 5 5

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 36.42 36.42 36.42 36.41 36.41 36.38 66.01 65.93 66.00
Public 63.58 63.58 63.58 63.59 63.59 63.62 33.99 34.07 34.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 30 Jan 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith Newspaper clippings of Un-Audited Financial Results for the quarter and half year ended on 31st December 2022 published in FREE PRESS JOURNAL and NAVSHAKTI on 29th January 2023 in pursuance of Regulation 47(3) of SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 which were approved in the Board meeting held on 28th January 2023
Sat, 28 Jan 2023
Sub: Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
We would like to inform you that the Board of Directors of the Company at their meeting held today i.e. 28th January 2023 has inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and nine-months ended on 31st December 2022.Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 28-01-2023 received from Vora & Associates Chartered Accountants Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and nine-months ended on 31st December 2022
Sat, 28 Jan 2023
Board Meeting Outcome for Sub: Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
We would like to inform you that the Board of Directors of the Company at their meeting held today i.e. 28th January 2023 has inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and nine-months ended on 31st December 2022.

Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 28-01-2023 received from Vora & Associates Chartered Accountants Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and nine-months ended on 31st December 2022.

Technical Scans View Details >>

Tue, 21 Mar 2023
Opening at High Opening at High
Opening at High for 3 days Opening at High for 3 days
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 965.30 +1.0%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,426.25 +0.2%
Divi's Laboratories Ltd. 73,553.38 2,776.75 +0.3%
Cipla Ltd. 69,632.88 855.50 -0.8%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,231.35 -1.0%
Torrent Pharmaceuticals Ltd. 51,277.87 1,512.15 -0.2%
Zydus Lifesciences Ltd. 48,378.30 480.50 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 965.30 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,426.25 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,776.75 +0.3%
Cipla Ltd. Consolidated 2022-12 26.39 855.50 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,231.35 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,512.15 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 480.50 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 965.30 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,426.25 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,776.75 +0.3%
Cipla Ltd. Consolidated 2022-12 3.07 855.50 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,231.35 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,512.15 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 480.50 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 965.30 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,426.25 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,776.75 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 855.50 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,231.35 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,512.15 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 480.50 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 965.30 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,426.25 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,776.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 855.50 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,231.35 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,512.15 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 965.30 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,426.25 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,776.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 855.50 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,231.35 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,512.15 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 965.30 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,426.25 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,776.75 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 855.50 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,231.35 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,512.15 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 480.50 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 965.30 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,426.25 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,776.75 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 855.50 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,231.35 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,512.15 -0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 480.50 +0.4%

FAQ's On Colinz Laboratories Ltd.

What is Colinz Laboratories share price?
Can I buy Colinz Laboratories shares now?
What is the Market Cap of Colinz Laboratories?
What are the key metrics to analyse Colinz Laboratories?
What is the 52 Week High and Low of Colinz Laboratories?
What is the trend of Colinz Laboratories share price?